ICYMI: A Recap of Blog Posts From AACR Annual Meeting 2022
From a joyous opening performance from the Preservation Hall All-Stars to a closing plenary that highlighted the full spectrum of cancer science, the American Association for Cancer Research (AACR) Annual Meeting 2022 provided a dynamic forum for the latest advances in cancer research.
The meeting, held in New Orleans from April 8-13, marked a successful return to an in-person format, following two years of remote meetings due to the COVID-19 pandemic. Approximately 19,000 people registered for this year’s meeting, with more than 15,000 attending in person.
AACR Chief Executive Officer Margaret Foti, PhD, MD (hc), was an enthusiastic host, telling the attendees in multiple sessions how vital their role is in the quest to prevent and cure cancer.
“Despite the challenges, this is an incredibly exciting, innovative, and hopeful time in cancer research,” Foti told one audience. “As reflected in the theme of this year’s meeting—Decoding Cancer Complexity, Integrating Science, Transforming Patient Outcomes—the pioneering strides you and your colleagues are making across the spectrum of cancer science are driving transformative progress against the disease at an exhilarating pace.”
From the initial call for abstracts to the meeting’s final plenary, Cancer Research Catalyst provided timely, insightful coverage of the meeting. Complementing AACR Meeting News, the AACR blog published 21 blog posts. Our blog staff will continue to draw upon the groundbreaking research presented at the meeting for future posts. But in case you missed any of our previous posts, here’s another look.
AACR Announces Call for Abstracts for AACR Annual Meeting 2022
We Can’t Wait to See You There
Uniting Scientists and Survivors
NFL’s Brandon Bolden Joins as AACR Ambassador
Global Scholars-in-Training to Gather in New Orleans
Transitions at the National Cancer Institute
Understanding and Intercepting Precancer
A New AACR Task Force to Promote Public Trust in Science
Opening Plenary Showcases Cutting-edge Scientific Program
The New Frontier of Immunotherapy in Lung Cancer: Boosting the Immune Response Before Surgery
How Do Tumors Evolve to Resist Therapy?
Integrating Complex Data and Diversity to Decode Cancer Disparities
Advancing Precision Immuno-oncology
AACR Project GENIE Delivers More Treasure
Extra, Extra! A Role for Extrachromosomal DNA in Cancer
Natural Killer Cells and the Antitumor Immune Response
T Cells Provide Hope for Cancer Patients Facing COVID-19
